Monthly Archives: March 2018

The CEO of BioMarin is Exercising Options

Yesterday, the CEO of BioMarin, Jean Jacques Bienaime, exercised options of BioMarin for $32.25K. Over the last month, Jean Jacques Bienaime has reported another 5 Buy trades on BMRN for a total of $1.22M. Based on BioMarin’s latest earnings report

The CEO of Widepoint Corp (NYSE MKT: WYY) is Buying Shares

Today, the CEO of Widepoint Corp (NYSE MKT: WYY), Jin Kang, bought shares of WYY for $11.1K. In addition to Jin Kang, one other WYY executive reported Buy trades in the last month. Based on Widepoint Corp’s latest earnings report

A Director at Kohl’s Corp is Exercising Options

Today, a Director at Kohl’s Corp, Stephen Watson, exercised options of Kohl’s Corp for $273K. The options were close to expired and Stephen Watson disposed stocks. Following Stephen Watson’s last KSS Sell transaction on June 27, 2017, the stock climbed

Barclays Sticks to Its Sell Rating for Brown & Brown

In a report released yesterday, Jay Gelb from Barclays maintained a Sell rating on Brown & Brown (NYSE: BRO), with a price target of $23. The company’s shares closed yesterday at $25.44. According to TipRanks.com, Gelb is a 5-star analyst

Barclays Believes PVH (NYSE: PVH) Still Has Room to Grow

Barclays analyst Chethan Mallela maintained a Buy rating on PVH (NYSE: PVH) yesterday and set a price target of $173. The company’s shares closed yesterday at $151.43, close to its 52-week high of $157.96. According to TipRanks.com, Mallela is a

Barclays Sticks to Their Buy Rating for Pfenex

Barclays analyst Douglas Tsao maintained a Buy rating on Pfenex (NYSEArca: PFNX) yesterday and set a price target of $8. The company’s shares closed on Wednesday at $6, close to its 52-week high of $6.77. According to TipRanks.com, Tsao is